Balance Sheet - Olema Pharmaceuticals, Inc. (OLMA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 505.44 | 434.09 | 261.81 | 204.42 | 287.25 | 338.55 | 0.07 | 3.15 |
| Accounts receivable, net | 4.06 | 2.12 | 0.67 | 0.32 | 0.13 | |||
| Inventories | -4.02 | -0.32 | -0.35 | |||||
| Other current assets | 5.96 | 2.27 | 4.03 | 4.16 | 3.31 | 3.59 | 0.04 | 0.09 |
| Total current assets | 515.45 | 438.47 | 266.51 | 208.90 | 290.69 | 342.14 | 0.10 | 3.24 |
| Total non-current assets | 17.98 | 12.51 | 10.43 | 6.75 | 5.26 | 0.59 | 0.03 | 0.03 |
| Total assets | 533.43 | 450.98 | 276.95 | 215.65 | 295.95 | 342.72 | 0.13 | 3.27 |
| Total current liabilities | 51.80 | 41.76 | 21.62 | 16.55 | 9.02 | 4.59 | 1.38 | 0.20 |
| Total non-current liabilities | 3.07 | 0.26 | 1.43 | 1.55 | 2.36 | 0.72 | 9.35 | 9.35 |
| Total liabilities | 54.87 | 42.02 | 23.05 | 18.10 | 11.38 | 4.59 | 10.73 | 9.55 |
| Total stockholders' equity | 478.56 | 408.96 | 253.90 | 197.55 | 284.57 | 338.14 | -10.59 | -6.28 |
| Common shares outstanding | 87 | 59 | 45 | 40 | 40 | 39 | 40 | 14 |
Show Quarterly Balance Sheet
Balance Sheet - Olema Pharmaceuticals, Inc. (OLMA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 505.35 | 505.44 | 328.96 | 361.91 | 392.71 | 434.09 | 214.76 | 239.10 | 248.98 | 261.81 | 276.90 | 167.44 | 185.95 | 204.42 | 222.60 | 240.71 | 267.87 | 287.25 | 305.95 | 318.14 | 326.97 | 338.55 | 127.82 | 0.00 | 0.07 | 0.07 |
| Accounts receivable, net | 4.06 | 2.97 | 2.75 | 1.92 | 2.12 | 0.69 | 0.82 | 0.66 | 0.67 | 0.74 | 0.62 | 0.30 | 0.32 | 0.46 | ||||||||||||
| Inventories | 2.27 | 4.09 | 3.21 | -0.30 | -0.32 | 1.92 | ||||||||||||||||||||
| Other current assets | 7.88 | 5.96 | 2.40 | 3.07 | 2.04 | 2.27 | 2.54 | 2.26 | 2.45 | 4.03 | 5.11 | 4.07 | 3.44 | 4.48 | 2.46 | 2.32 | 2.35 | 3.44 | 2.33 | 2.71 | 3.30 | 3.59 | 1.26 | 0.04 | ||
| Total current assets | 513.23 | 515.45 | 334.33 | 367.73 | 396.66 | 438.47 | 217.99 | 242.19 | 252.09 | 266.51 | 282.01 | 171.51 | 189.40 | 208.90 | 225.06 | 243.03 | 270.21 | 290.69 | 308.28 | 320.85 | 330.27 | 342.14 | 129.09 | 0.07 | 0.10 | |
| Total non-current assets | 17.42 | 17.98 | 18.12 | 14.28 | 12.98 | 12.51 | 12.18 | 12.37 | 11.60 | 10.43 | 10.79 | 6.12 | 6.37 | 6.75 | 6.94 | 7.57 | 7.20 | 5.26 | 1.52 | 1.38 | 1.04 | 0.59 | 1.60 | -0.07 | 0.03 | |
| Total assets | 530.65 | 533.43 | 352.45 | 382.00 | 409.64 | 450.98 | 230.17 | 254.56 | 263.69 | 276.95 | 292.80 | 177.62 | 195.77 | 215.65 | 232.00 | 250.60 | 277.42 | 295.95 | 309.80 | 322.23 | 331.30 | 342.72 | 130.68 | 0.13 | ||
| Total current liabilities | 47.17 | 51.80 | 41.66 | 33.16 | 26.06 | 41.76 | 30.70 | 26.54 | 26.22 | 21.62 | 15.97 | 14.83 | 19.41 | 16.55 | 12.55 | 12.31 | 10.17 | 9.02 | 8.90 | 8.15 | 5.28 | 4.59 | 5.27 | 1.38 | ||
| Total non-current liabilities | 3.00 | 3.07 | 3.31 | 3.60 | 0.12 | 0.26 | 0.56 | 0.86 | 1.15 | 1.43 | 1.70 | 1.21 | 1.38 | 1.55 | 1.75 | 2.01 | 2.16 | 2.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.35 | ||
| Total liabilities | 50.17 | 54.87 | 44.97 | 36.77 | 26.19 | 42.02 | 31.26 | 27.39 | 27.38 | 23.05 | 17.67 | 16.04 | 20.79 | 18.10 | 14.30 | 14.32 | 12.33 | 11.38 | 8.90 | 8.15 | 5.28 | 4.59 | 5.27 | 10.73 | ||
| Total stockholders' equity | 480.48 | 478.56 | 307.49 | 345.24 | 383.45 | 408.96 | 198.91 | 227.16 | 236.32 | 253.90 | 275.13 | 161.58 | 174.98 | 197.55 | 217.70 | 236.28 | 265.09 | 284.57 | 300.89 | 314.08 | 326.02 | 338.14 | 125.41 | -1.25 | -10.59 | |
| Common shares outstanding | 103 | 91 | 86 | 85 | 85 | 59 | 57 | 56 | 56 | 55 | 45 | 41 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 39 | 39 | 20 | 38 | 14 | 14 | 14 |